Based on our analyses performed, we show that SMARCB1 (INI1)-deficient neoplasms are very rare and most likely represent a spectrum of known tumor types, namely epithelioid sarcoma, MRT and undifferentiated carcinoma rather than a distinct entity. This evidence concerns the gene SMARCB1 and neoplasm.